Ligand Pharmaceuticals (LGND) Net Equity Issued and Repurchased (2010 - 2026)
Ligand Pharmaceuticals' Net Equity Issued and Repurchased came in at $106.45 million for Q2 2026, compared with $8.24 million a year earlier.
Powered by 
Analysis
Ligand Pharmaceuticals (LGND) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Ligand Pharmaceuticals reported Net Equity Issued and Repurchased of $122.34 million, up 130.0% year-over-year; for FY2025, it came in at $67.39 million, up 2.7% from FY2024.
- Net Equity Issued and Repurchased has increased in each of the last three years, with a five-year compound annual growth rate of 86.1% (FY2020 to FY2025).
- Going back by year, Net Equity Issued and Repurchased was $65.59 million in FY2024 (+192.2%), $22.45 million in FY2023 (+594.6%), $3.23 million in FY2022 (-90.4%) and $33.76 million in FY2021.
- The Q2 2026 figure represents the highest quarterly Net Equity Issued and Repurchased in data going back to Q3 2010.
- Year-over-year, Net Equity Issued and Repurchased increased in three of the last five quarters, with growth averaging 144.6%.
- The fastest year-over-year change in Net Equity Issued and Repurchased over five years came in Q1 2023 (growth of 877.8%), and the weakest in Q1 2022 (a decline of 98.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Ligand Pharmaceuticals | 6.22 Bn | 2.69 Bn | - | 106.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 106.45 Mn |
| Mar 31, 2026 | 7.65 Mn |
| Sep 30, 2025 | 54.93 Mn |
| Jun 30, 2025 | 8.24 Mn |
| Mar 31, 2025 | 4.22 Mn |
| Dec 31, 2024 | 19.34 Mn |
| Sep 30, 2024 | 21.40 Mn |
| Jun 30, 2024 | 9.55 Mn |
| Mar 31, 2024 | 15.30 Mn |
| Dec 31, 2023 | 6.53 Mn |
| Sep 30, 2023 | 3.39 Mn |
| Jun 30, 2023 | 9.14 Mn |
| Mar 31, 2023 | 3.39 Mn |
| Dec 31, 2022 | 1.40 Mn |
| Sep 30, 2022 | 820,000.00 |
| Jun 30, 2022 | 664,000.00 |
| Mar 31, 2022 | 347,000.00 |
| Dec 31, 2021 | 4.28 Mn |
| Sep 30, 2021 | 1.90 Mn |
| Jun 30, 2021 | 1.09 Mn |
API Access
Ligand Pharmaceuticals Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=LGND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "LGND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=LGND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();